New study tests smart glucose monitor for diabetes patients after hospital stay
NCT ID NCT05360056
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study looks at whether wearing a continuous glucose monitor (CGM) after leaving the hospital helps people with type 2 diabetes control their blood sugar. About 108 adults who need insulin will wear a CGM for 12 weeks and answer surveys about their experience. The goal is to see if the device improves time in a healthy blood sugar range and patient satisfaction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
108 people
The number who actually took part.
- Started
-
Apr 2022
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Type 2 Diabetes * Basal insulin use \>10 units per day * Hemoglobin A1c \>8.0% * Smartphone compatible with Clarity App * Age ≥18 years Exclusion Criteria: * Type 1 DM * Inability to consent * Pregnancy * Prisoners * Discharge to skilled nursing facility
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Ohio State University Medical Center - Outpatient Care East
Columbus, Ohio, 43203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cost-Effectiveness and implementation of integrated Diabetes-Oral health care in oman: a health belief Model-Based intervention to enhance clinical, behavioral, and exploratory oral microbiome in health system outcomes in type 2 diabetes
- Fibrinogen to albumin ratio (FAR) as a risk factor for type 2 diabetic Nephropathy(DN)
- A digital coach for hunger: can an app retrain appetite to improve diabetes control?
- Can a numbing gel on the feet beat a daily pill for diabetic nerve pain?
- Can a crocosmia bulb compound tame type 2 diabetes?
- Can a wearable sensor improve blood sugar control in hospitals?